OVID
Ovid Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.80
+0.72%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+16.1%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 8, 2026 | Carter Charles Ross · officer: Chief Financial Officer | A-Award | 50,000 | $0.00 |
| Jun 17, 2026 | Greka Anna · director | A-Award | 130,000 | $2.26 |
| Apr 9, 2026 | PAPADOPOULOS STELIOS · director | A-Award | 17,578 | $2.56 |
| Apr 9, 2026 | Fitzgerald Kevin Joseph · director | A-Award | 17,578 | $2.56 |
| Apr 9, 2026 | Friedman Bart · director | A-Award | 8,789 | $2.56 |
| Mar 25, 2026 | LEVIN JEREMY M · director, officer: Executive Chairman | M-Exempt | 47,333 | $1.40 |
| Mar 2, 2026 | DUNCAN BARBARA GAYLE · director | A-Award | 65,000 | $1.65 |
| Mar 2, 2026 | Fitzgerald Kevin Joseph · director | A-Award | 65,000 | $1.65 |
| Mar 2, 2026 | LEVIN JEREMY M · director | A-Award | 957,000 | $1.65 |
| Mar 2, 2026 | PAPADOPOULOS STELIOS · director | A-Award | 65,000 | $1.65 |
| Mar 2, 2026 | Rona Jeffrey A · officer: CBFO | Sale | 8,541 | $1.45 |
| Mar 2, 2026 | Bernstein Karen · director | A-Award | 65,000 | $1.65 |
| Mar 2, 2026 | ALEXANDER MARGARET A. · director, officer: President and CEO | A-Award | 1,435,000 | $1.65 |
| Mar 2, 2026 | ALEXANDER MARGARET A. · director, officer: President and CEO | Sale | 11,656 | $1.45 |
| Mar 2, 2026 | Rona Jeffrey A · officer: CBFO | A-Award | 408,750 | $1.65 |
| Mar 2, 2026 | Rona Jeffrey A · officer: CBFO | A-Award | 68,125 | $0.00 |
| Mar 2, 2026 | Friedman Bart · director | A-Award | 65,000 | $1.65 |
| Jan 5, 2026 | ALEXANDER MARGARET A. · director, officer: President and CEO | A-Award | 890,000 | $1.76 |
| Dec 18, 2025 | LEVIN JEREMY M · director, officer: CEO | Purchase | 71 | $0.00 |
| Dec 18, 2025 | LEVIN JEREMY M · director, officer: CEO | Purchase | 47,333 | $1.40 |
| Dec 18, 2025 | LEVIN JEREMY M · director, officer: CEO | Purchase | 35,500 | $1.40 |
| Jun 18, 2025 | Friedman Bart · director | A-Award | 45,000 | $0.57 |
| Jun 18, 2025 | Bernstein Karen · director | A-Award | 45,000 | $0.57 |
| Jun 18, 2025 | Fitzgerald Kevin Joseph · director | A-Award | 45,000 | $0.57 |
| Jun 18, 2025 | Duncan Barbara Gayle · director | A-Award | 45,000 | $0.57 |
| Mar 4, 2025 | PAPADOPOULOS STELIOS · director | A-Award | 90,000 | $0.49 |
| Feb 28, 2025 | Rona Jeffrey A · officer: CBFO | Sale | 3,902 | $0.56 |
| Feb 28, 2025 | ALEXANDER MARGARET A. · officer: President and COO | Sale | 5,279 | $0.56 |
| Feb 24, 2025 | Rona Jeffrey A · officer: CBFO | A-Award | 262,500 | $0.57 |
| Feb 24, 2025 | LEVIN JEREMY M · director, officer: CEO | A-Award | 1,650,000 | $0.57 |
Institutional positioning
13F filings over the trailing two quarters
New 30Increased 32Reduced 24Sold out 101
| Filer | Action | Shares | Filed |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | New Position | 10,714,000 | May 18, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Unchanged | 10,714,000 | May 15, 2026 |
| AFFINITY ASSET ADVISORS, LLC | Increased | 10,636,318 | May 14, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | Increased | 9,916,911 | May 15, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Increased | 6,163,781 | May 15, 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | Increased | 5,533,073 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 5,258,246 | May 15, 2026 |
| ADAR1 CAPITAL MANAGEMENT, LLC | Reduced | 4,544,113 | May 18, 2026 |
| SATURN V CAPITAL MANAGEMENT LLC | Increased | 4,166,666 | May 15, 2026 |
| FEDERATED HERMES, INC. | Unchanged | 3,571,000 | May 11, 2026 |
| IKARIAN CAPITAL, LLC | Increased | 2,894,704 | May 15, 2026 |
| ALLY BRIDGE GROUP (NY) LLC | Increased | 2,818,459 | May 18, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Increased | 2,171,094 | May 15, 2026 |
| BLUE OWL CAPITAL HOLDINGS LP | New Position | 1,904,666 | May 14, 2026 |
| SPHERA FUNDS MANAGEMENT LTD. | New Position | 1,622,828 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 8, 2026